Research progress on the molecular mechanisms of PD-1 and LAG-3 synergy in regulating T cell exhaustion and immunotherapy

Despite demonstrated efficacy, challenges including variable response rates, resistance mechanisms, and immune-related adverse events remain. Future efforts should prioritize biomarker identification and regimen optimization to enable precision application of dual blockade.